Back to top
more

ReWalk Robotics Ltd (RWLK)

(Delayed Data from NSDQ)

$3.76 USD

3.76
197,465

+0.05 (1.35%)

Updated May 3, 2019 04:00 PM ET

After-Market: $3.74 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

ReWalk Robotics (RWLK) Reports Q2 Loss, Tops Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of 28.57% and 0.15%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) delivered earnings and revenue surprises of 8.33% and 18.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Shilpa Mete headshot

Robotics & Automation Gaining Momentum: 4 Stocks in Focus

Robotics continues to boom as it aids automation. Here's a peek into four stocks that are well-poised to capitalize on growth prospects related to robotics technology.

ReWalk Robotics (RWLK) Reports Q1 Loss, Misses Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of 12.50% and 38.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 0.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 0% and 6.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Artivion (AORT) Q1 Earnings and Revenues Beat Estimates

Artivion (AORT) delivered earnings and revenue surprises of 166.67% and 2.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q4 Loss, Tops Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -28.57% and 3.76%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Dynatronics Corporation (DYNT) Reports Q2 Loss, Lags Revenue Estimates

Dynatronics Corporation (DYNT) delivered earnings and revenue surprises of -80% and 0.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IRadimed (IRMD) Q4 Earnings Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 3.23% and 0.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -50% and 51.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 50% and 12.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Integer (ITGR) Surpasses Q3 Earnings Estimates

Integer (ITGR) delivered earnings and revenue surprises of 6.74% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q2 Loss, Misses Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -75% and 32.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Eli Lilly (LLY) Lags Q2 Earnings and Revenue Estimates

Lilly (LLY) delivered earnings and revenue surprises of -30.56% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Edwards Lifesciences (EW) Matches Q2 Earnings Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0% and 1.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -40% and 60.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 0% and 7.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates

Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -17.07% and 5.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates

Masimo (MASI) delivered earnings and revenue surprises of 1.09% and 3.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Accuray (ARAY) Reports Q3 Loss, Misses Revenue Estimates

Accuray (ARAY) delivered earnings and revenue surprises of 83.33% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q4 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -50% and 30.62%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

ReWalk (RWLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

All You Need to Know About ReWalk (RWLK) Rating Upgrade to Buy

ReWalk (RWLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).